Etoposide in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

NCT00002880 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

DRUG: Etoposide phosphate

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]